Literature DB >> 26899323

IGF-I stimulates ERβ and aromatase expression via IGF1R/PI3K/AKT-mediated transcriptional activation in endometriosis.

Yan Zhou1, Cheng Zeng1, Xin Li1, Pei-Li Wu1, Ling Yin1, Xiao-Lan Yu1, Ying-Fang Zhou1, Qing Xue2.   

Abstract

UNLABELLED: Estrogen receptor beta (ERβ, encoded by ESR2 gene) and cytochrome P450 aromatase (encoded by CYP19A1 gene) play critical roles in endometriosis, and the levels of insulin-like growth factor-I (IGF-I) in the peritoneal fluid are significantly higher in patients with endometriosis compared with those in normal women. However, the effects and mechanisms of IGF-I on ERβ and aromatase expression remain to be fully elucidated. In this study, human endometriotic stromal cells (ESCs) and endometrial cells (EMs) derived from ovarian endometriomas and eutopic endometrial tissues. ESCs were cultured with IGF-I, signal pathway inhibitors, and siRNAs. ERβ and aromatase expression were measured by real-time PCR and Western, respectively. The binding of c-Jun and CREB to the ESR2 and CYP19A1 promoters was assessed by chromatin immunoprecipitation assay. Animal experiments were performed in a xenograft mouse model. Levels of IGF-I mRNA in ESCs were markedly higher than those in EMs. IGF-I upregulated ERβ and aromatase expression in ESCs after stimulation of the IGF1R/PI3K/AKT pathway. Following IGF-I treatment, a marked increase in c-Jun and CREB phosphorylation occurred, enhancing binding to the ESR2 and CYP19A1 promoters. An IGF1R inhibitor in vivo reduced IGF-I-induced endometriosis graft growth and ERβ and aromatase expression. In conclusion, this is the first report to describe a mechanistic analysis of ERβ and aromatase expression regulated by IGF-I in ESCs. Moreover, an IGF1R inhibitor impeded ectopic lesion growth in nude mice. These findings suggest that an inhibitor of IGF1R might have therapeutic potential as an antiendometriotic drug. KEY MESSAGES: Level of IGF-I mRNA in ESCs is markedly higher than that in EMs. IGF-I up-regulates ERβ and aromatase expression via IGF1R/PI3K/AKT pathway. C-Jun and CREB are recruited to ESR2 or CYP19A1 promoter by IGF-I stimulation. IGF-1R inhibitors in vivo impede the growth of ectopic lesions in nude mice.

Entities:  

Keywords:  Aromatase; ERβ; Endometriosis; IGF-I; IGF1R inhibitor; IGF1R/PI3K/AKT pathway

Mesh:

Substances:

Year:  2016        PMID: 26899323     DOI: 10.1007/s00109-016-1396-1

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  50 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis.

Authors:  Xunqin Yin; Mary Ellen Pavone; Zhenxiao Lu; JianJun Wei; J Julie Kim
Journal:  J Clin Endocrinol Metab       Date:  2011-11-09       Impact factor: 5.958

Review 3.  Targeting insulin and insulin-like growth factor signaling in breast cancer.

Authors:  Yuzhe Yang; Douglas Yee
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-10-10       Impact factor: 2.673

4.  Molecular mechanisms of insulin-like growth factor-I mediated regulation of the steroidogenic acute regulatory protein in mouse leydig cells.

Authors:  Pulak R Manna; Syam P Chandrala; Steven R King; Youngah Jo; Raymond Counis; Ilpo T Huhtaniemi; Douglas M Stocco
Journal:  Mol Endocrinol       Date:  2005-09-15

Review 5.  Aromatase and other steroidogenic genes in endometriosis: translational aspects.

Authors:  E Attar; S E Bulun
Journal:  Hum Reprod Update       Date:  2005-08-25       Impact factor: 15.610

6.  Cloning and characterization of human estrogen receptor beta promoter.

Authors:  L C Li; C C Yeh; D Nojima; R Dahiya
Journal:  Biochem Biophys Res Commun       Date:  2000-08-28       Impact factor: 3.575

7.  Nandrolone and stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation.

Authors:  Rosa Sirianni; Claudia Capparelli; Adele Chimento; Salvatore Panza; Stefania Catalano; Marilena Lanzino; Vincenzo Pezzi; Sebastiano Andò
Journal:  Mol Cell Endocrinol       Date:  2012-08-10       Impact factor: 4.102

8.  Endometrial-peritoneal interactions during endometriotic lesion establishment.

Authors:  M Louise Hull; Claudia Rangel Escareno; Jane M Godsland; John R Doig; Claire M Johnson; Stephen C Phillips; Stephen K Smith; Simon Tavaré; Cristin G Print; D Stephen Charnock-Jones
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

9.  Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro.

Authors:  I P Ryan; E D Schriock; R N Taylor
Journal:  J Clin Endocrinol Metab       Date:  1994-03       Impact factor: 5.958

10.  Increased mitogen-activated protein kinase kinase/extracellularly regulated kinase activity in human endometrial stromal fibroblasts of women with endometriosis reduces 3',5'-cyclic adenosine 5'-monophosphate inhibition of cyclin D1.

Authors:  Michael C Velarde; Lusine Aghajanova; Camran R Nezhat; Linda C Giudice
Journal:  Endocrinology       Date:  2009-07-09       Impact factor: 4.736

View more
  10 in total

1.  Altered gene expression of VEGF, IGFs and H19 lncRNA and epigenetic profile of H19-DMR region in endometrial tissues of women with endometriosis.

Authors:  Sedigheh Kamrani; Elham Amirchaghmaghi; Firouzeh Ghaffari; Maryam Shahhoseini; Kamran Ghaedi
Journal:  Reprod Health       Date:  2022-04-22       Impact factor: 3.355

2.  A Novel Method to Differentiate Tonsil-Derived Mesenchymal Stem Cells In Vitro into Estrogen-Secreting Cells.

Authors:  Hee-Yeon Kim; Younghay Lee; Hee-Soo Yoon; Yu-Hee Kim; Kyong-A Cho; So-Youn Woo; Han Sun Kim; Bo-Young Park; Sung-Chul Jung; Inho Jo; Woo-Jae Park; Joo-Won Park; Kyung-Ha Ryu
Journal:  Tissue Eng Regen Med       Date:  2020-10-28       Impact factor: 4.169

Review 3.  Villainous role of estrogen in macrophage-nerve interaction in endometriosis.

Authors:  Yanchun Liang; Hongyu Xie; Jinjie Wu; Duo Liu; Shuzhong Yao
Journal:  Reprod Biol Endocrinol       Date:  2018-12-05       Impact factor: 5.211

4.  Macrophage-derived insulin-like growth factor-1 is a key neurotrophic and nerve-sensitizing factor in pain associated with endometriosis.

Authors:  Rachel Forster; Alexandra Sarginson; Atanaska Velichkova; Chloe Hogg; Ashley Dorning; Andrew W Horne; Philippa T K Saunders; Erin Greaves
Journal:  FASEB J       Date:  2019-07-10       Impact factor: 5.191

5.  Expression levels of MCP-1, HGF, and IGF-1 in endometriotic patients compared with non-endometriotic controls.

Authors:  Sahel Heidari; Roya Kolahdouz-Mohammadi; Sepideh Khodaverdi; Nader Tajik; Ali-Akbar Delbandi
Journal:  BMC Womens Health       Date:  2021-12-20       Impact factor: 2.809

6.  Reduced cardiovascular risks in women with endometriosis or polycystic ovary syndrome carrying a common functional IGF1R variant.

Authors:  Mark J Powell; Sophia Fuller; Erica P Gunderson; Christopher C Benz
Journal:  Hum Reprod       Date:  2022-05-03       Impact factor: 6.353

Review 7.  The Double Engines and Single Checkpoint Theory of Endometriosis.

Authors:  Che-Fang Hsu; Aye Aye Khine; Hsuan-Shun Huang; Tang-Yuan Chu
Journal:  Biomedicines       Date:  2022-06-14

Review 8.  Mechanisms for estrogen receptor expression in human cancer.

Authors:  Hui Hua; Hongying Zhang; Qingbin Kong; Yangfu Jiang
Journal:  Exp Hematol Oncol       Date:  2018-09-19

Review 9.  Estrogen disorders: Interpreting the abnormal regulation of aromatase in granulosa cells (Review).

Authors:  Ting Liu; Yifei Huang; Hui Lin
Journal:  Int J Mol Med       Date:  2021-03-11       Impact factor: 4.101

Review 10.  Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis.

Authors:  Sun-Wei Guo
Journal:  Reprod Med Biol       Date:  2018-08-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.